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The current A(H1N1) flu has showed sub-population dependent susceptibility and fatality as early as 
April and May of 2009 in its first wave of spreading. After the pandemic outbreak spreads globally for 
more than seven months, the subpopulation dependence of this flu, including ethnicity, age and gender 
selectivity, has been recognized by several research groups. This paper attempts to discussed how to 
identify ethnic selectivity from the released data by WHO relevant to this ongoing flu, review some 
recently published papers describing the presence of ethnic differences in susceptibilities to the H1N1 
flu virus and further raised an argument that ethnic differences in susceptibilities to a virus might be a 
piece of evidence reflecting a weak virulence of that specific virus.  
 





The morbidity and mortality of an infectious disease de-
pend on the interaction between the pathogen and its 
host under specific environments. For viral infections in 
humans, the size of the susceptible subpopulation to a 
new type or subtype of virus largely determines the 
spreading width and the overall morbidity globally, 
whereas the viral virulence is associated with the morta-
lity related to the specific virus. In other words, a pande-
mic outbreak may only cause a very low mortality when 
the virus is moderately or weakly virulent and a high 
death toll or high morbidity is generally reported as a 
result of a disease outbreak caused by a virulent virus.  
It is well known that genetic heterogeneity or gene 
make-up plays a role in variable morbidity and mortality 
rates of both non-infectious and infectious diseases 
(Modiano et al., 1996; Neel, 1962; Schwartz, 2001; World 
Health Statistics, 2008). The ethnic difference in disease 
susceptibility is an advantageous gain during the 
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ways. Firstly, the same ethnic group may have selected 
susceptibilities to different pathogens and secondly, 
various ethnic groups may have different susceptibilities 
to the same pathogen. Therefore, it is possible to express 
various morbidity and mortality rates among people 
depending on their ethnicities, regions, ages among 
others, during an epidemic particularly during a pandemic 
outbreak. 
As early as April 29 and May 6 2009, an opinion was 
expressed that ethnic selectivity to the ongoing H1N1 
might be a factor in minimizing the death toll of the new 
flu outbreak and Chinese population might not be highly 
susceptible to the N1H1 virus. This was presented to the 
public and biomedical communities (http://blog.sina.com. 
cn/s/blog_4e5eb50f0100deyl.html) (Zhou et al. 2009). At 
the epidemiological point of view, ethnic difference can be 
revealed by analyses of some specific epidemiologic 
parameters. For example, the following parameters can 
be used to evaluate whether there is an ethnic difference 
in susceptibility: i). the time interval between the first im-
ported case and the first domestic case; ii). the case 
doubling time; iii). the ratio of symptomless infected  
individuals and clinically diagnosed cases; iv). the ratio of 
cases without contact history and those with clear contact  




history; v). The morbidity rate observed in different ethnic 
groups and vi). The case fatality ratios among ethnic 
groups.  
It was first noticed that the possible ethnic dependent 
susceptibilities to A (H1N1) flu from the significant diffe-
rences of case doubling time among countries in late 
April of 2009 and virtually all patients diagnosed in the 
first month since its transmission to China were input 
cases without single domestic second generation case 
until May 29 of 2009 (http://www.gowod.cn/html/42/n-
4642.html). More solid evidence was from WHO update 
providing death toll by countries, which clearly docu-
mented significant differences among the case fatality 
ratio among countries (Figure 1b) (Pandemic (H1N1) 
2009 - update 72). The North American region showed 
relatively high case fatality ratio, which is probably 
attributed to both ethnic and regional selectivity. Based on 
the latest update of WHO, the case fatality ratios were 
different among regions (Figure 1a) (Pandemic (H1N1) 
2009 - update 71). Ethnicity dependent susceptibility to A 
(H1N1) flu has now been recognized by both biomedical 
community and the general public. Using the parameters 
mentioned above, one study from New Zealand reported 
ethnic related susceptibilities to H1N1 viral infection 
(Baker et al., 2009). Interestingly, National Geographic 
News published on October 9, 2009 reported that native 
peoples are suffering a swine flu infection rate four to five 
times higher than that of the general population (http:// 
news.nationalgeographic.com/news/2009/10/091009-
swine-flu-deaths-children-pediatric-indigenous.html). This 
newspaper also recalled similar ethnic selectivity in the 
Spanish influenza pandemic in 1918 in which indigenous 
peoples in Canada, Sweden, Norway and the United 
States had estimated mortality rates 3 to 70 times higher 
than non-indigenous populations. It seems that ethnic 
selectivity, rather than health care conditions is respon-
sible for the major difference in modality and mortality 
rates observed among ethnic groups. As shown in Figure 
1, a more reasonable explanation for the extremely low 
case fatality ratio as well as mortality rate in China so far 
during the A (H1N1) flu is ethnic dependent susceptibility, 
rather than the stringent strategies used in the 
prevention.  
Early identification of highly susceptible subgroup is 
very important in order to provide medical services to 
those who are at high risk. In addition to ethnic sub-
groups, the current A (H1N1) flu also showed age and 
gender dependent modality and mortality rates different 
from other subpopulations. Young people and women 
with pregnancy have been confirmed to be high risk sub-
populations, probably in any ethnic groups (Jain et al., 
2009; Jamieson et al., 2009; CDC, 2009). Further report 
showed that the estimated rate of admission for 
pandemic H1N1 influenza virus infection in pregnant 
women during the first month of the outbreak was higher 
than it was in the general population (0.32 per 100 000 





(Jamieson et al., 2009). In a report including 272 hospi-
talized patients, forty-five percent of the patients were 
children under the age of 18 (Jain et al., 2009). In 
particular situations, a case fatality ratio in hospitalized 
young flu patients had been reported in as high as 50% 
(Caprotta et al., 2009). Mechanisms responsible for age- 
and ethnic-dependent susceptibility to A (H1N1) flu are 
probably different. The former is more related to prior 
natural or artificial immunization and the latter is highly 
possibly attributed to the genetic heterogeneity of human 
beings.  
In fact, it is already well recognized by the scientific 
community that the new H1N1 virus is far less virulent 
than what was predicted by official authorities even with-
out the present prospective evaluation of its virulence. 
Compared to the predicted daily death rate of about 1000 
patients from seasonal flu (250,000 to 500,000 fatal 
cases per year), the H1N1 flu caused an average less 
than 30 deaths daily in the past six months (Goodman et 
al., 2006; Pandemic (H1N1) 2009 - update 72). The lack 
of a commonly accepted criteria for the prospective eva-
luation of viral virulence caused a certain confusion in the 
public community between the WHO’s alert stages and 
the viral virulence degrees (WHO), and led to some 
misinterpretations on its viral virulence. 
The prospective evaluation of virulence of a new 
pathogen has enormous social and biomedical impacts. 
In order to be more effectively and cost-efficiently pre-
pared in dealing with a new disease outbreak, assessing 
how virulent the new pathogen is will be the most impor-
tant factor in determining the mobilization scale and inten-
sity of the infection nationally or internationally. For this 
ongoing pandemic flu outbreak, intensive strategies such 
as national vacation with the shutting down of schools 
and businesses seemed like the proper response at the 
beginning when the prospective virulence was thought to 
be highly virulent. However, when ethnic and age 
differences in the propagation of the flu were observed, 
these intensive strategies might not be necessary any-
more.  
The traditional reporting system which presents data on 
the number of infected cases and death toll does not pro-
vide enough information for prospective virulence evalua-
tion and has only limited value in guiding the prevention. 
The suggested classification requires more epidemiology-
related parameters for the prospective evaluation of viral 
virulence. Whenever possible, ethnicity, age, gender and 
all other parameters included in this classification system 
should be released for adequate epidemiological study. In 
the present ongoing pandemic outbreak of the H1N1 flu, 
the identification of the higher susceptibility of young 
people and pregnant women is a reminder that more 
medical surveillance of these two subpopulations is re-
quired. If the ethnicity-related information would have 
been included and the ethnic difference officially reported 
during the early stages of this pandemic swine flu, an 
overreaction   would   probably  have  been  avoided  and  










Figure 1. Different susceptibility to A (H1N1) flu among regions and countries. 
The regions in 1a represent the WHO Regional Offices for: Africa (AFRO), 
Americas (AMRO), Eastern Mediterranean (EMRO), Europe (EURO), South-
East Asia (SEARO) and Western Pacific (WPRO). This data was the 
Cumulative total as of 18 October 2009. 1b: Mortality rates of selected 
countries including Mexico, the country of the A (H1N1) outbreak origin. The 
death toll was the latest update between August 4th and October 26 of 2009 




precious resources used more effectively for specific 
subgroups such as young persons and pregnant women 
of specific ethnic groups. 
The prospective evaluation of a new pathogen’s viru-
lence is not only able to provide an abstract classification 
number, but it also helps to estimate the worst mortality 
rate of the specific pathogen and to estimate the possible 
gap between the retrospective mortality and the worst 
prospective mortality. The worst mortality is simply 
extrapolated globally using the local mortality of a region 
or a nation where the outbreak of the new infectious 
disease begins. For example, the worst fatality of this A 
(H1N1) can be estimated using the regional mortality in 
the first wave in Mexico by simply assuming the same 
level of global mortality it would be. That is, roughly a 
maximum of 14,000 to 70,000 fatal cases would be even-
tually accumulated in this new flu outbreak depending on 
how the regional mortality is calculated with the 
population of the country of Mexico or the city of Mexico. 
If there is no second wave of A (H1N1) flu outbreak in 
Mexico, the maximal number of death toll would be 
14,000 or less. Otherwise, if a second wave occurs in 
Mexico, the worst death toll would then be 70,000 or less 
globally. This estimation is solely based on ethnic selec-
tivity without taking seasonal factor into account. There-
fore, the real worst situation of the death toll may reach or 
even a little bit more than 70,000. The death toll from this 
theoretical worst situation is still better  than  the  average  
b 




number caused by seasonal flu. Thus, the prospectively 
evaluation of the ongoing spreading virus is not only 
theoretically useful but also with practical high impact to 
the national or international mobilization in battling with 
the spread of the new disease.  
This prospective evaluation of viral virulence can be 
used for quick adjustments in handling outbreaks of viral 
diseases particularly the pandemic outbreaks. The viru-
lence classification helps to predict the worst global 
mortality and estimate the gap between the prospective 
mortality and the retrospective mortality, which can be 
used to decide the scale of national or international mobi-
lization in battling with the spread of the new disease, 
such as the decision of preparing a given amount of 
specific antiviral medicine and specific vaccine. Addi-
tionally, the assessment of susceptibilities among selec-
ted groups can help to focus on the prevention and 
treatment efforts or the international collaborations in 
targeting ethnic groups with high susceptibility, and to 
minimize overreactions in ethnic groups with low suscep-
tibility. The ethnic differences are not just a concept. 
These differences can be identified quantitatively in a 
number of epidemiologic parameters. There is no doubt 
that the identification of different susceptibilities among 
various ethnic groups to a specific virus means that the 
viral virulence is relatively low and thus not a high risk to 
human beings. It is urgently needed in order to have a 
virulence classification adding to WHO's disease repor-
ting system. The suggested inclusion of ethnic dependent 
susceptibility to viral infection discussed in the present 
paper cannot fulfill this important issue but it opens a new 
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